Endovastec Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Public

  • Employees
  • 822

Employees

  • Stock Symbol
  • 688016

Stock Symbol

  • Share Price
  • $12.94
  • (As of Friday Closing)

Endovastec General Information

Description

Shanghai MicroPort Endovascular MedTech (Group) Co Ltd is engaged in the research and development (R&D), manufacturing, sales and services of aortic, peripheral vascular and tumor intervention devices. Its product portfolio includes thoracic and abdominal aortic stent grafts, peripheral vascular stents, drug-coated balloon dilatation catheters, balloon dilatation catheters, vena cava filters, snare retrieval kits, thrombectomy devices, and tumor embolization microspheres. The company markets its products in China and international markets, including Europe, Latin America, Asia, and Africa.

Contact Information

Website
www.endovastec.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • Building 1, 3399, Kangxin Road, Pudong New Area
  • Shanghai, 201318
  • China
+86 021
Primary Industry
Diagnostic Equipment
Stock Exchange
SHG
Corporate Office
  • Building 1, 3399, Kangxin Road, Pudong New Area
  • Shanghai, 201318
  • China
+86 021

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Endovastec Stock Performance

As of 13-Nov-2026, Endovastec’s stock price is $12.94. Its current market cap is $1.6B with 123M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$12.94 $12.79 $12.26 - $16.85 $1.6B 123M 1.24M $0.70

Endovastec Financials Summary

As of 30-Sep-2026, Endovastec has a trailing 12-month revenue of $211M.

In Thousands,
USD 		TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 1,251,689 1,314,779 1,520,602 2,126,054
Revenue 211,062 187,814 168,118 167,806
EBITDA 97,343 100,646 95,709 84,821
Net Income 84,559 78,334 69,975 69,603
Total Assets 751,391 663,334 587,882 599,019
Total Debt 2,093 2,141 5,597 5,043
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Endovastec Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Endovastec‘s full profile, request access.

Request a free trial

Endovastec Patents

  • 13

    Total Documents Applications and Grants

  • Total Patents Families

  • 8

    Granted

  • Pending

  • Expiring in next 12 mo

Endovastec Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2020258943-A1 Filter recovering and protecting device, filter recovering system and method and filtering system Inactive 28-Jun-2019
WO-2020134593-A1 Delivery system for medical implant Inactive 29-Dec-2018
WO-2019137456-A1 Handle for medical implant delivery system Inactive 12-Jan-2018
WO-2019128485-A1 Thrombus retrieval catheter Inactive 26-Dec-2017
US-10080674-B2 Branched stent graft, delivery system comprising same and method of fabricating same Active 04-Mar-2013 A61F2/856
To view Endovastec’s complete patent history, request access »

Endovastec Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Endovastec ESG

Risk Overview

Risk Rating

Updated September, 30, 2025

29.38 | Med Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 14,999

Rank

Percentile

Healthcare

Industry

of 665

Rank

Percentile

Medical Devices

Subindustry

of 235

Rank

Percentile

To view Endovastec’s complete esg history, request access »

Endovastec FAQs

  • When was Endovastec founded?

    Endovastec was founded in 2012.

  • Where is Endovastec headquartered?

    Endovastec is headquartered in Shanghai, China.

  • What is the size of Endovastec?

    Endovastec has 822 total employees.

  • What industry is Endovastec in?

    Endovastec’s primary industry is Diagnostic Equipment.

  • Is Endovastec a private or public company?

    Endovastec is a Public company.

  • What is Endovastec’s stock symbol?

    The ticker symbol for Endovastec is 688016.

  • What is the current stock price of Endovastec?

    As of 13-Nov-2026 the stock price of Endovastec is $12.94.

  • What is the current market cap of Endovastec?

    The current market capitalization of Endovastec is $1.6B.

  • What is Endovastec’s current revenue?

    The trailing twelve month revenue for Endovastec is $211M.

  • What is Endovastec’s annual earnings per share (EPS)?

    Endovastec’s EPS for 12 months was $0.70.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process